Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
#4491 Expression and clinical significance of IGFBP-3 in pituitary neuroendocrine tumours
Introduction: IGFBP-3 is a regulatory factor highly expressed in pituitary neuroendocrine tumours that may provide reference for the clinical diagnosis and treatment of pituitary neuroendocrine tumours.
Conference:
Presenting Author:
Authors: Hu Y, Yuan C, Tang Y,
Keywords: IGFBP-3, Pituitary neuroendocrine tumour,
Introduction: Patients with neuroendocrine tumours have a long course of disease, facing not only physical pain but also complex psychological changes.
Conference:
Presenting Author: Tang Y
Authors: Xie W, Gu T, Tang Y, Liu G, Zhu Y,
Keywords: neuroendocrine tumour, narrative care, case care,
#4457 Primary mixed hepatocellular carcinoma-neuroendocrine carcinoma: A case report
Introduction: Mixed epithelial neoplasms (MiNENs) are characterised by the coexistence of neuroendocrine and non-neuroendocrine components within a single tumour, each discernible histologically and immunohistochemically, with a minimum tumour proportion of 30%. Primary hepatic MiNENs are exceedingly rare entities.
Conference:
Presenting Author: Tang Y
Authors: Wang Y, Wang R, Yi X, Guo M, Tang Y,
Keywords: pancreatic neuroendocrine tumour, functional, parathyroid hormone related peptide,
Introduction: Neuroendocrine tumours can occur in multiple parts of the body, and management faces challenges.
Conference:
Presenting Author:
Authors: Liu G, Gu T, Tang Y, Xie W, Zhu Y,
Keywords: neuroendocrine tumour, novel wound materials, symptom management,
#4426 A case of giant neuroendocrine tumour of unknown primary site
Introduction: The liver is a common site for metastatic neuroendocrine tumours. NETs primary to the liver are rare, and it is difficult to determine whether a neuroendocrine tumour in the liver is primary or metastatic in patients in whom no tumour has been found elsewhere.
Conference:
Presenting Author: Yingmei T
Authors: Jieting D, Yanping Z, Yingmei T, Rongfang T, Yan W,
Keywords: neuroendocrine tumour, primary hepatic neuroendocrine tumour, metastatic,
Our website automatically sets cookies, which are technically necessary for the operation of the website. By clicking "OK", Google Analytics and the associated cookies are also activated for the purpose of website analysis and optimization. Detailed Information and the possibility to revoke your consent at any time, you can find in our privacy policy.
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.
For more information about how Google Analytics handles user data, see Google's privacy policy: https://support.google.com/analytics/answer/6004245?hl=en.